Wuxi AppTec Co (SHSE:603259) Debt-to-EBITDA : (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603259 Wuxi AppTec Co Ltd SHSE:603259
87 GF Score
Price ¥167.96
GF Value ¥100.77
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Wuxi AppTec Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Wuxi AppTec Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ¥12,939 Mil. Wuxi AppTec Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was ¥2,190 Mil. Wuxi AppTec Co's annualized EBITDA for the quarter that ended in Jun. 2026 was ¥35,815 Mil. Wuxi AppTec Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 0.42.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Wuxi AppTec Co's Debt-to-EBITDA or its related term are showing as below:

SHSE:603259' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.28   Med: 0.44   Max: 1.72
Current: 0.31

During the past 11 years, the highest Debt-to-EBITDA Ratio of Wuxi AppTec Co was 1.72. The lowest was 0.28. And the median was 0.44.

SHSE:603259's Debt-to-EBITDA is ranked better than
80.51% of 118 companies
in the Medical Diagnostics & Research industry
Industry Median: 2.475 vs SHSE:603259: 0.31

Wuxi AppTec Co  (SHSE:603259) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Wuxi AppTec Co Debt-to-EBITDA Related Terms

Wuxi AppTec Co Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Wuxi AppTec Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wuxi AppTec Co Debt-to-EBITDA Chart

Wuxi AppTec Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Wuxi AppTec Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SHSE:603259 vs TMO, DHR, NTRA: Debt-to-EBITDA Comparison

For the Diagnostics & Research subindustry, Wuxi AppTec Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuxi AppTec Co Debt-to-EBITDA vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's Debt-to-EBITDA falls into.


SHSE:603259
87GF Score
Wuxi AppTec Co Ltd SHSE:603259
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wuxi AppTec Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Wuxi AppTec Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(6145.75651994 + 2274.35665487) / 27339.55379099
=0.31

Wuxi AppTec Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(12939.12 + 2189.783) / 35815.45038632
=0.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is Wuxi AppTec Co (SHSE:603259) Overvalued in 2026?

Based on GuruFocus' analysis, Wuxi AppTec Co stock appears to be overvalued. The current stock price of ¥167.96 is trading 66.7% above its estimated GF Value™ of ¥100.77. GuruFocus considers Wuxi AppTec Co to be Significantly Overvalued.

Key valuation signals for SHSE:603259:

  • Debt-to-EBITDA:
  • GF Value™: ¥100.77 vs. price of ¥167.96 (66.7% above fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603259 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wuxi AppTec Co Business Description

Address 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by PRC, Europe, and other regions.
87GF Score

Get the complete analysis for SHSE:603259

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥167.96
Price
¥100.77
GF Value